We are live on
!
Find out more
TC
Tejara Capital Portfolio holdings
AUM
$303M
1-Year Est. Return
5.43%
This Fund
S&P 500
This Quarter
Est. Return
+7.71%
1 Year Est. Return
+5.43%
3 Year Est. Return
+13.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$239M
AUM Growth
+$62.9M
(+36%)
Cap. Flow
+$47.6M
Cap. Flow
% of AUM
19.96%
Top 10 Holdings %
Top 10 Hldgs %
47.13%
Holding
79
New
15
Increased
27
Reduced
17
Closed
11
Top Buys
| 1 |
Roivant Sciences
ROIV
|
+$17.3M |
| 2 |
Newmont
NEM
|
+$8.93M |
| 3 |
Liberty Global Class A
LBTYA
|
+$8.58M |
| 4 |
Nabors Industries
NBR
|
+$7.66M |
| 5 |
Scorpio Tankers
STNG
|
+$4.71M |
Top Sells
| 1 |
Citigroup
C
|
+$13.4M |
| 2 |
Cameco
CCJ
|
+$7.35M |
| 3 |
Peabody Energy
BTU
|
+$4.8M |
| 4 |
Collegium Pharmaceutical
COLL
|
+$3.72M |
| 5 |
CNR
Core Natural Resources Inc
CNR
|
+$3.35M |
Sector Composition
| 1 | Healthcare | 38.1% |
| 2 | Energy | 31.79% |
| 3 | Materials | 9.33% |
| 4 | Financials | 6.54% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Roivant Sciences
ROIV
$25.1B
| $24M | 10.04% |
2,134,895
+1,776,323
| +495% | +$17.3M |
|
2
Golar LNG
GLNG
$5.16B
| $11.7M | 4.89% |
508,280
| – | – |
|
3
Teva Pharmaceuticals
TEVA
$36.7B
| $11M | 4.62% |
1,056,006
+233,511
| +28% | +$2.18M |
|
|
4
Nabors Industries
NBR
$1.22B
| $10.9M | 4.54% |
132,925
+79,024
| +147% | +$7.66M |
|
|
5
Newmont
NEM
$102B
| $9.57M | 4.01% |
+231,300
| New | +$8.93M |
|
|
6
Liberty Global Class A
LBTYA
$3.64B
| $9.41M | 3.94% |
+529,500
| New | +$8.58M |
|
|
BORR
7
Borr Drilling
BORR
$1.33B
| $9.28M | 3.89% |
1,261,193
+41,888
| +3% | +$276K |
|
|
8
Scorpio Tankers
STNG
$3.91B
| $9.16M | 3.84% |
150,721
+83,600
| +125% | +$4.71M |
|
9
Heron Therapeutics
HRTX
$83.1M
| $8.97M | 3.76% |
5,275,236
+3,165,555
| +150% | +$3.49M |
|
|
MREO
10
Mereo BioPharma
MREO
$52.3M
| $8.58M | 3.59% |
3,713,129
+498,128
| +15% | +$953K |
|
11
NOV
NOV
$6.96B
| $8.13M | 3.41% |
401,065
+60,000
| +18% | +$1.18M |
|
|
12
Citigroup
C
$230B
| $7.9M | 3.31% |
153,621
-302,690
| -66% | -$13.4M |
|
13
Viatris
VTRS
$19.4B
| $6.64M | 2.78% |
612,815
+146,100
| +31% | +$1.4M |
|
14
The GEO Group
GEO
$3.98B
| $6.1M | 2.56% |
563,244
+155,000
| +38% | +$1.48M |
|
15
BGC Group
BGC
$5.38B
| $5.89M | 2.47% |
816,072
-102,740
| -11% | -$636K |
|
16
Orthofix Medical
OFIX
$456M
| $5.31M | 2.23% |
394,095
+184,300
| +88% | +$2.17M |
|
17
Freeport-McMoran
FCX
$87.6B
| $5.18M | 2.17% |
+121,700
| New | +$4.49M |
|
18
Rekor Systems
REKR
$91M
| $4.85M | 2.03% |
1,456,589
+711,008
| +95% | +$2.03M |
|
|
SCPH
19
DELISTED
scPharmaceuticals
SCPH
| $4.75M | 1.99% |
757,771
+656,357
| +647% | +$3.76M |
|
20
Forum Energy Technologies
FET
$594M
| $4.64M | 1.94% |
209,090
| – | – |
|
|
21
Collegium Pharmaceutical
COLL
$1.19B
| $4.34M | 1.82% |
141,099
-148,704
| -51% | -$3.72M |
|
22
Transocean
RIG
$5.76B
| $3.91M | 1.64% |
+615,000
| New | +$4.12M |
|
23
Noble Corp
NE
$6.47B
| $3.87M | 1.62% |
80,445
+58,445
| +266% | +$2.73M |
|
|
24
Peabody Energy
BTU
$2.87B
| $3.68M | 1.54% |
151,267
-199,023
| -57% | -$4.8M |
|
25
Arcutis Biotherapeutics
ARQT
$3.47B
| $3.59M | 1.5% |
1,112,217
+803,038
| +260% | +$2.18M |
|
Similar funds
OFG
EC
ECAM
RFM
BPH
DFG
BCC
BKA